TORONTO - January 5, 2018 - (Newswire.com)
PureSinse Inc. (“PureSinse” or the “Company”), a privately held vertically integrated and export-driven cannabis company, today announced that on Dec. 28, 2017, it was the 83rd applicant to be granted a coveted cultivation license by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), for its facility located in Brampton, Ontario. PureSinse anticipates that its unique licensing strategy will enable the Company to achieve Sales Licensing, its next value generating milestone, with significantly less time and initial capital outlay than its peers, and begin revenue generation in the first quarter of 2018.
“The attainment of our license is a historical landmark for PureSinse as it allows us to begin deployment of our multi-channel business model in the burgeoning Canadian and global Cannabis marketplace while supporting the growth of other premium quality Licensed Producer partners. It was an incredibly long journey of over three years to get to this point. Leveraging our deep knowledge and experience in the pharmaceutical, nutraceutical, commercial horticulture, IT, and consumer goods industries, we look forward to providing consistently safe and trusted cannabis products that consumers can depend upon,” commented Malay Panchal, CEO and Chairman. “PureSinse will sell cannabis products sourced only from high-quality Licensed Producers who meet stringent quality assurance standards, or produced through its own pharmaceutical grade manufacturing techniques, eliminating the use of any pesticides. We look forward to a period of unprecedented growth ahead of us and making a positive difference in the lives of many,” Mr. Panchal added.
PureSinse’s main site is an 18,000 square foot facility, that will soon be a hub for processing, production, R&D, and distribution, located in the heart of the Greater Toronto Hamilton Area near major thruways and the Toronto international airport. Utilizing modern commercial horticulture and hydroponic techniques, the site will produce over 4,000 kg of premium quality dried cannabis per year.
About: PureSinse Inc. is an innovative, Toronto-based Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company’s focus is on producing premium quality cannabis products, delivering best-in-class client service, and catering to the needs of wellness cannabis consumers for both medical and future legal adult-use markets. Visit www.puresinse.com to learn more.
Public Inquiries: Malay (Mel) Panchal, Chairman and CEO
Related Links
Website for prospective investors
Press Release Service by Newswire.com
Original Source: PureSinse Inc. Granted Coveted ACMPR License From Health Canada
